These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23995153)

  • 41. The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs.
    Falissard B; Mauri M; Shaw K; Wetterling T; Doble A; Giudicelli A; De Hert M
    Int Clin Psychopharmacol; 2011 Nov; 26(6):291-302. PubMed ID: 21876442
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The common pathophysiology underlying the metabolic syndrome, schizophrenia and depression. A review.
    Kucerova J; Babinska Z; Horska K; Kotolova H
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):208-14. PubMed ID: 25485531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mental illness and metabolic syndrome--a literature review.
    Łopuszańska UJ; Skorzyńska-Dziduszko K; Lupa-Zatwarnicka K; Makara-Studzińska M
    Ann Agric Environ Med; 2014; 21(4):815-21. PubMed ID: 25528926
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis.
    Bora E; Akdede BB; Alptekin K
    Psychol Med; 2017 Apr; 47(6):1030-1040. PubMed ID: 28032535
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic syndrome in schizophrenia.
    Malhotra N; Grover S; Chakrabarti S; Kulhara P
    Indian J Psychol Med; 2013 Jul; 35(3):227-40. PubMed ID: 24249923
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The prevalence and mechanisms of metabolic syndrome in schizophrenia: a review.
    Papanastasiou E
    Ther Adv Psychopharmacol; 2013 Feb; 3(1):33-51. PubMed ID: 23983991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Effects of Hopelessness and Some Variables on Metabolic Syndrome in Schizophrenia Patients.
    Çevik Durmaz Y; Menekli T; Ersoy Özcan B
    Clin Nurs Res; 2022 Feb; 31(2):194-201. PubMed ID: 34930066
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of metabolic syndrome with schizophrenia.
    Bajaj S; Varma A; Srivastava A; Verma AK
    Indian J Endocrinol Metab; 2013 Sep; 17(5):890-5. PubMed ID: 24083172
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patients with schizophrenia show raised serum levels of the pro-inflammatory chemokine CCL2: association with the metabolic syndrome in patients?
    Drexhage RC; Padmos RC; de Wit H; Versnel MA; Hooijkaas H; van der Lely AJ; van Beveren N; deRijk RH; Cohen D
    Schizophr Res; 2008 Jul; 102(1-3):352-5. PubMed ID: 18486454
    [No Abstract]   [Full Text] [Related]  

  • 50. The multidimensional nature of metabolic syndrome in schizophrenia: lessons from studies of one-carbon metabolism and DNA methylation.
    Misiak B; Frydecka D; Piotrowski P; Kiejna A
    Epigenomics; 2013 Jun; 5(3):317-29. PubMed ID: 23750646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic Hormones in Schizophrenia Patients with Antipsychotic-Induced Metabolic Syndrome.
    Boiko AS; Mednova IA; Kornetova EG; Goncharova AA; Semke AV; Bokhan NA; Ivanova SA
    J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294794
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia.
    Malan-Müller S; Kilian S; van den Heuvel LL; Bardien S; Asmal L; Warnich L; Emsley RA; Hemmings SM; Seedat S
    Schizophr Res; 2016 Jan; 170(1):1-17. PubMed ID: 26621002
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intrinsic Therapeutic Link between Recuperative Cerebellar Con-Nectivity and Psychiatry Symptom in Schizophrenia Patients with Comorbidity of Metabolic Syndrome.
    Zhou J; Guo X; Liu X; Luo Y; Chang X; He H; Duan M; Li S; Li Q; Tan Y; Yao G; Yao D; Luo C
    Life (Basel); 2023 Jan; 13(1):. PubMed ID: 36676092
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia.
    Boiko AS; Mednova IA; Kornetova EG; Semke AV; Bokhan NA; Loonen AJM; Ivanova SA
    Heliyon; 2019 Jul; 5(7):e02033. PubMed ID: 31317083
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deciphering the paradoxical incidence of cancer in schizophrenia.
    Kuppili PP; Nebhinani N
    Australas Psychiatry; 2018 Dec; 26(6):624-627. PubMed ID: 30226103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Animal models of metabolic syndrome: a review.
    Wong SK; Chin KY; Suhaimi FH; Fairus A; Ima-Nirwana S
    Nutr Metab (Lond); 2016; 13():65. PubMed ID: 27708685
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of Metabolic Syndrome in Patients with Schizophrenia According to the Presence or Absence of Negative Symptoms.
    Sicras-Mainar A; Ruiz-Beato E; Mauriño J; Navarro-Artieda R
    Value Health; 2014 Nov; 17(7):A456. PubMed ID: 27201269
    [No Abstract]   [Full Text] [Related]  

  • 58. The metabolic syndrome and schizophrenia: A comorbidity or an association?
    Bou Khalil R
    J Pharmacol Pharmacother; 2013 Jul; 4(3):174-5. PubMed ID: 23960421
    [No Abstract]   [Full Text] [Related]  

  • 59. Metabolic variations in schizophrenia.
    LARUE GH; PAINCHAUD CA; NADEAU G
    Can Med Assoc J; 1950 Jun; 62(6):581-4. PubMed ID: 15420655
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.